Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Assets (2016 - 2026)

Sanofi's Assets history spans 18 years, with the latest figure at $149.9 billion for Q1 2026.

  • On a quarterly basis, Assets rose 8.04% to $149.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $149.9 billion, a 8.04% increase, with the full-year FY2025 number at $147.6 billion, up 4.02% from a year prior.
  • Assets hit $149.9 billion in Q1 2026 for Sanofi, up from $147.6 billion in the prior quarter.
  • Over the last five years, Assets for SNY hit a ceiling of $151.7 billion in Q3 2025 and a floor of $7.0 billion in Q4 2022.
  • Historically, Assets has averaged $129.2 billion across 5 years, with a median of $139.7 billion in 2024.
  • Biggest five-year swings in Assets: fell 3.9% in 2022 and later skyrocketed 1832.58% in 2023.
  • Tracing SNY's Assets over 5 years: stood at $7.0 billion in 2022, then skyrocketed by 1832.58% to $136.1 billion in 2023, then grew by 4.29% to $141.9 billion in 2024, then increased by 4.02% to $147.6 billion in 2025, then rose by 1.54% to $149.9 billion in 2026.
  • Business Quant data shows Assets for SNY at $149.9 billion in Q1 2026, $147.6 billion in Q4 2025, and $151.7 billion in Q3 2025.